INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
PATIENT REVENUES, net	$ 119,987	$ 117,550
EXPENSES:
Operating	94,859	94,422
Lease and rent expense	13,512	13,115
Professional liability	1,839	1,851
General and administrative	6,758	7,213
Depreciation and amortization	2,288	2,317
Total expenses	119,256	118,918
OPERATING INCOME (LOSS)	731	(1,368)
OTHER INCOME (EXPENSE):
Other income	115	160
Interest expense, net	(1,460)	(1,394)
Total other expense	(1,345)	(1,234)
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(614)	(2,602)
BENEFIT FOR INCOME TAXES	104	1,028
LOSS FROM CONTINUING OPERATIONS	(510)	(1,574)
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit of $65 and $73, respectively	(243)	(1,772)
NET LOSS	$ (753)	$ (3,346)
Per common share – basic
Continuing operations (in dollars per share)	$ (0.08)	$ (0.24)
Discontinued operations (in dollars per share)	(0.04)	(0.28)
Net loss per common share – basic (dollars per share)	(0.12)	(0.52)
Per common share – diluted
Continuing operations (in dollars per share)	(0.08)	(0.24)
Discontinued operations (in dollars per share)	(0.04)	(0.28)
Net income (loss) per common share – diluted (dollars per share)	$ (0.12)	$ (0.52)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,506	6,424
Diluted (shares)	6,506	6,424